Please provide your email address to receive an email when new articles are posted on . The estimated added effect of provocation was not significant for either condition. The findings have ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
The MarketWatch News Department was not involved in the creation of this content. Phoenix, Arizona--(Newsfile Corp. - March 26, 2026) - Camelback Integrated Health and Wellness, a Phoenix-based ...
If you’ve struggled with treatment resistant depression, anxiety or OCD, you’re a candidate for Deep TMS. At Kansas City ...
BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRSYF) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
NEWPORT NEWS, Va., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers, one of the leading providers of mental health services in the United States, is now offering BrainsWay’s Deep ...
Here in the U.S., some 21 million adults experience at least one major depressive episode each year. About a third of them do not achieve adequate relief from traditional antidepressant medications ...
Phoenix Clinic Expands Access to FDA-Cleared Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder and a Range of Other Conditions Phoenix, Arizona--(Newsfile Corp. - March 26, 2026) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results